跳至主要内容
临床试验/NCT04657952
NCT04657952Unknown4 期

Sphenopalatine Ganglion Block With Adrenaline Additive for Post-Dural Puncture Headache in Orthopedic Patients: A Randomized Controlled Study

Tanta University0 个研究点目标入组 60 人开始时间: 2020年12月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
60
主要终点
Efficacy of analgesia demonstrated by visual analogue scale (VAS) less than 4 (effective) in the first 48 hours

研究概览

简要总结

The aim of this study is to assess the efficacy, onset and duration of analgesia of sphenopalatine ganglion bock (SPGB) using lidocaine 4% with adrenaline as a treatment of postoperative Post dural puncture headache (PDPH) of orthopedic patients after lower limbs surgeries.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Admitted to the orthopedic department
  • Complaining of criteria of severe post-dural puncture headache within 7 days following subarachnoid block used for lower limbs surgeries.
  • American Society of Anesthesiologists (ASA) physical status I and II.

排除标准

  • Patient refusal or uncooperative.
  • Patients with uncontrollable hypertension.
  • Patient with known coagulopathy.
  • Patient with nasal septal deviation, polyp, history of nasal bleeding.
  • Patient with allergy to local anesthetics
  • American Society of Anesthesiologists physical status>2.

研究组 & 干预措施

Standard medical Treatment (paracetamol)

Active Comparator

Patients will receive paracetamol 1 gm every 6 hours daily intravenously for a day.

干预措施: Medical Treatment (Drug)

Sphenopalatine block

Experimental

Patients will receive sphenopalatine block

干预措施: Sphenopalatine Ganglion Block (Procedure)

结局指标

主要结局

Efficacy of analgesia demonstrated by visual analogue scale (VAS) less than 4 (effective) in the first 48 hours

时间窗: 48 hours

Efficacy of analgesia demonstrated by visual analogue scale (VAS) less than 4 (effective) in the first 48 hours. VAS ranges from 0 to 10; 10 with worse outcome

次要结局

  • Duration of analgesia(48 hours)
  • Adverse events(48 hours)
  • Onset of analgesia(48 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hussen Gamal Almawardy

Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine

Tanta University

相似试验

Sphenopalatine Ganglion Block for Post-Dural... | 临床试验